抗利尿薬の市場規模、シェア、成長分析、タイプ別、適応症別、流通チャネル別、地域別 - 産業予測、2025年～2032年

抗利尿薬の世界市場規模は2023年に17億米ドルと評価され、2024年の18億米ドルから2032年には30億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは6.7%で成長する見通しです。

抗利尿薬の世界市場は、人口の高齢化、希少な腎臓疾患やホルモン疾患に対する意識の高まり、こうした治療を必要とする疾患の早期かつ正確な特定を促進する診断技術の進歩などを背景に、大きな成長を遂げています。慢性疾患の管理と患者の健康増進への絶え間ない関心が、これらの医薬品、特にデスモプレシンとバソプレシンアナログへの需要を急増させています。デスモプレシンは主要な抗利尿薬として頭角を現し、特に夜尿症の子供や成人の間で、その幅広い処方率によってかなりの市場シェアを獲得しています。製薬会社は、患者のコンプライアンス向上を目指して、口腔内崩壊錠や点鼻薬などの革新的な製剤への投資を増やしています。しかし、医薬品の安全性や潜在的な副作用に関する懸念が高まっているため、規制当局による精査が必要となっています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 顧客購買行動分析

抗利尿薬市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• バソプレシン
• デスモプレシン
• オキシトシン
• その他

抗利尿薬市場規模：適応症別& CAGR（2025-2032）

• 市場概要
• 尿崩症
• 血友病
• 高血圧
• その他

抗利尿薬市場規模：流通チャネル別& CAGR（2025-2032）

• 市場概要
• 病院薬局
• 小売薬局
• オンライン薬局

抗利尿薬市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Sanofi
• Ferring Pharmaceuticals
• Pfizer Inc.
• Novartis AG
• Otsuka Holdings Co., Ltd.
• Teva Pharmaceutical Industries Ltd.
• Taj Pharmaceuticals Limited
• Par Sterile Products, LLC
• Mallinckrodt
• CSL Limited
• Fresenius Kabi
• Azevan Pharmaceuticals, Inc.

結論と提言

Global Antidiuretic Drugs Market size was valued at USD 1.7 billion in 2023 and is poised to grow from USD 1.8 billion in 2024 to USD 3.05 billion by 2032, growing at a CAGR of 6.7 % in the forecast period (2025-2032).

The global market for antidiuretic drugs is experiencing significant growth, driven by an aging population, heightened awareness of rare kidney and hormonal disorders, and advancements in diagnostic technologies that facilitate earlier and more accurate disease identification requiring such treatments. The relentless focus on managing chronic illnesses and enhancing patient well-being has surged the demand for these medications, particularly desmopressin and vasopressin analogs. Desmopressin has emerged as the leading antidiuretic drug, capturing a substantial market share through its extensive prescription rates, especially among children and adults with nocturnal enuresis. Pharmaceutical companies are increasingly investing in innovative drug formulations, such as orally disintegrating tablets and nasal sprays, aimed at improving patient compliance. However, growing concerns related to drug safety and potential side effects necessitate ongoing regulatory scrutiny.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antidiuretic Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antidiuretic Drugs Market Segments Analysis

The global antidiuretic drugs marketis segmented into type, indication, distribution channel, and region. By product, the market is classified into vasopressin, desmopressin, oxytocin, and others. Depending on the indication, it is divided into diabetes insipidus, hemophilia, hypertension, and other. According to distribution channel, the market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Antidiuretic Drugs Market

The growth of the global antidiuretic drugs market is primarily driven by the increasing prevalence of diabetes insipidus, a rare chronic condition characterized by excessive thirst and urination due to impaired water regulation in the body. This condition requires long-term treatment, creating a sustained demand for antidiuretic medications such as desmopressin and vasopressin. Furthermore, heightened awareness and improved diagnosis of related disorders, including nocturnal enuresis and certain kidney diseases, are further bolstering market expansion. As more patients receive diagnoses and subsequent treatment with these essential medications, the market is experiencing a significant upward trajectory.

Restraints in the Global Antidiuretic Drugs Market

A significant challenge facing the global antidiuretic drugs market is the prohibitively high pricing of these medications. Many antidiuretic treatments, particularly innovative and patented options, tend to be expensive, limiting their accessibility to patients in low- and middle-income countries. Moreover, the necessity for extended or lifelong treatment for conditions like diabetes insipidus further escalates costs. Consequently, these financial barriers can dissuade both patients and healthcare systems from adopting these therapies, ultimately hindering overall market expansion. Without addressing affordability, the potential for growth in this sector may be significantly constrained.

Market Trends of the Global Antidiuretic Drugs Market

The Global Antidiuretic Drugs market is experiencing a significant trend towards innovative drug formulations and delivery methods that prioritize patient convenience and compliance. Manufacturers are actively developing a range of novel delivery systems, such as orally disintegrating tablets, nasal sprays, and long-acting injectables. These advancements are particularly beneficial for vulnerable populations, including the elderly and pediatrics, who may struggle with traditional medication forms. Such innovations not only improve patient adherence to treatment regimens but also enhance the overall therapeutic efficacy of antidiuretic drugs, driving growth and competition within the market as stakeholders seek to address diverse patient needs effectively.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Antidiuretic Drugs Market Size by Type & CAGR (2025-2032)

• Market Overview
• Vasopressin
• Desmopressin
• Oxytocin
• Others

Global Antidiuretic Drugs Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Diabetes Insipidus
• Hemophilia
• Hypertension
• Other

Global Antidiuretic Drugs Market Size by Distribution channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Antidiuretic Drugs Market Size & CAGR (2025-2032)

• North America (Type, Indication, Distribution channel)
  • US
  • Canada
• Europe (Type, Indication, Distribution channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, Distribution channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, Distribution channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, Distribution channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Holdings Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taj Pharmaceuticals Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Par Sterile Products, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azevan Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations